Ludwig Enterprises (LUDG) Cash from Financing Activities (2022 - 2026)
Ludwig Enterprises (LUDG) reported Cash from Financing Activities of $170982.0 for Q1 2026, up 72.03% on a YoY basis from $99392.0 in Q1 2025, and up 1590.05% quarter-over-quarter from $10117.0 in Q4 2025.
Ludwig Enterprises (LUDG) Cash from Financing Activities (2022 - 2026) Analysis & Trends
Ludwig Enterprises has reported Cash from Financing Activities for 5 years, with the latest figure at $170982.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities rose 72.03% year-over-year to $170982.0; the trailing twelve-month figure through Mar 2026 stood at $718857.0 (up 125.98% YoY), and the FY2025 full-year result was $647267.0, up 15.85% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $170982.0, up from $10117.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $755000.0 in Q4 2022, with the low at $10117.0 in Q4 2025.
- Historically, Cash from Financing Activities has averaged $215632.5 across 5 years, with a median of $99708.0 in 2024.
- The largest YoY upside for Cash from Financing Activities was 532.66% in 2025 against a maximum downside of 89.85% in 2025.
- Ludwig Enterprises' Cash from Financing Activities stood at $755000.0 in 2022, then sank by 77.48% to $170000.0 in 2023, then slumped by 41.35% to $99708.0 in 2024, then slumped by 89.85% to $10117.0 in 2025, then jumped by 1590.05% to $170982.0 in 2026.
- The last three Cash from Financing Activities figures came in at $170982.0 (Q1 2026), $10117.0 (Q4 2025), and $537758.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Ludwig Enterprises | - | - | - | 170,982.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 170,982.00 |
| Mar 31, 2026 | 170,982.00 |
| Dec 31, 2025 | 10,117.00 |
| Dec 31, 2025 | 10,117.00 |
| Jun 30, 2025 | 537,758.00 |
| Jun 30, 2025 | 537,758.00 |
| Mar 31, 2025 | 99,392.00 |
| Mar 31, 2025 | 99,392.00 |
| Dec 31, 2024 | 99,708.00 |
| Dec 31, 2024 | 99,708.00 |
| Sep 30, 2024 | 34,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 85,000.00 |
| Jun 30, 2024 | 85,000.00 |
| Mar 31, 2024 | 340,000.00 |
| Mar 31, 2024 | 340,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Mar 31, 2023 | 70,000.00 |
| Mar 31, 2023 | 70,000.00 |